
Fields | Project/Modality | Target | Indications | Pre-clinical | Phase Ⅰ | Phase Ⅱ | Phase Ⅲ | Trial Regions | Rights Regions | Partner |
---|---|---|---|---|---|---|---|---|---|---|
Nephropathy | SC0062 SM |
ETA | lgA |
![]() |
![]() |
|||||
DKD |
![]() |
![]() |
||||||||
Oncology | BC3195 ADC |
CDH3 | Soild tumor |
![]() ![]() |
![]() |
|||||
Oncology | BC3402 mAb |
TIM-3 | HCC |
![]() |
![]() |
![]() |
||||
MDS/CMML |
![]() ![]() |
![]() |
||||||||
Oncology | BC3448 BsAb |
CD3xEGFR | Solid tumor |
![]() ![]() |
![]() |
|||||
Oncology | SC0191 SM |
WEE1 | Solid tumor |
![]() |
![]() |
|||||
Solid tumor |
![]() |
![]() |
||||||||
OC |
![]() |
![]() |
||||||||
Oncology | SC0245 SM |
ATR | Solid tumor |
![]() |
![]() |
|||||
SCLC |
![]() |
![]() |
||||||||
Oncology | BC3425 mAb |
4-1BB | Solid tumor |
![]() |
![]() |
|||||
Oncology | ADC | Undisclosed | Solid tumor | ![]() |
||||||
Oncology | Bs-Ab | Undisclosed | Solid tumor | ![]() |